Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.0%

2 terminated out of 25 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

20%

5 trials in Phase 3/4

Results Transparency

21%

3 of 14 completed with results

Key Signals

3 with results88% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (10)
P 1 (1)
P 2 (4)
P 3 (1)
P 4 (4)

Trial Status

Completed14
Recruiting3
Terminated2
Unknown2
Active Not Recruiting1
Withdrawn1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07426471Not Yet RecruitingPrimary

Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections.

NCT07359651Recruiting

FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).

NCT05826873Not ApplicableActive Not Recruiting

Discharge Stewardship in Children's Hospitals

NCT05471908Not ApplicableRecruiting

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

NCT07107555Enrolling By Invitation

Necrotizing Soft Tissue Infections

NCT04257097Not ApplicableCompleted

Reinforced PTFE Meshes Versus Customized Titanium Meshes

NCT02979951Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

NCT03982030Phase 4Withdrawn

Dalbavancin Outpatient Pilot

NCT05814003Not ApplicableUnknownPrimary

Clinical Effectiveness of Polymethoxy Flavones Solid Dispersion as a Dressing Material for Palatal Grafts Donor Sites

NCT04286334Not ApplicableCompleted

Three-dimensional Bone Regeneration Using Custom-made Meshes With and Without Collagen Membrane

NCT04393909Not ApplicableCompleted

Improving Safety of Diagnosis and Therapy in the Inpatient Setting

NCT03643952Phase 2Completed

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

NCT04332679Not ApplicableCompleted

Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes

NCT02600871Phase 4Completed

Skin and Soft Tissue Infection (SSTI) Study

NCT01790698CompletedPrimary

Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).

NCT00451386Phase 2Completed

Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)

NCT00303589Phase 2CompletedPrimary

A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

NCT02097615Phase 4CompletedPrimary

Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water

NCT00102947Phase 4TerminatedPrimary

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

NCT02595047Not ApplicableUnknownPrimary

Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint)

Scroll to load more

Research Network

Activity Timeline